Follow Us      


   Official Journal of The Academy of Osseointegration

Share Page:

Volume 29 , Issue 1
January/February 2009

Pages 31-39

Clinical Application of Bisphosphonates in Implant Dentistry: Histomorphometric Evaluation

Francesco Zuffetti, MD, DDS/Francesca Bianchi, MD, DDS/ Raffaele Volpi, MD, DDS/Paolo Trisi, DMD/Massimo Del Fabbro, BSC, PhD/Matteo Capelli, DMD/Fabio Galli, MD, DDS/ Franco Capsoni, MD/Tiziano Testori, MD, DDS

PMID: 19244880
DOI: 10.11607/prd.00.0846

Bisphosphonates are pharmacologic compounds characterized by high tropism to bone tissue. They affect bone metabolism by inhibition of osteoclast recruitment, proliferation, differentiation, and function. Because they can reduce bone resorption, bisphosphonates are used mainly for the treatment of osteometabolic conditions, particularly osteoporosis, Paget disease, multiple myeloma, and other solid tumors with bone metastases. Their use has conferred great benefits to patients affected by these diseases, significantly improving their quality of life. Bisphosponates’ inhibition of bone resorption might be exploited to maintain implant primary stability during the process of implant osseointegration. The aim of this histologic clinical study was to compare the response of bone tissue around an implant treated with a bisphosphonate solution (test) to that of the bone around an untreated implant (control). The bisphosphonate-treated implant showed more contact with newly formed bone than the control implant. (Int J Periodontics Restorative Dent 2009;29:31–39.)

Full Text PDF File | Order Article


Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.


© 2020 Quintessence Publishing Co, Inc

PRD Home
Current Issue
Ahead of Print
Author Guidelines
Submission Form
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us